Keith Goldan

(Mr. Keith Goldan CPA)

Currently holds a position at OptiNose Inc

Positions

Position Company Period
Chief Financial Officer OptiNose Inc Jan. 1, 2017 -
Chief Financial Officer Fibrocell Science Inc Nov. 4, 2016 - Jan. 1, 2017
Chief Financial Officer, Principal Accounting Officer Fibrocell Science Inc June 1, 2015 - Nov. 4, 2016
Chief Financial Officer, Senior Vice President, Treasurer, Corporate Secretary Fibrocell Science Inc March 18, 2015 - June 1, 2015
Keith Goldan's trades of Syndax Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-12 2025-02-10
S Sale
3,777 -4.0%
15.50
USD 58,559 		3,777 -4.0% 15.50 USD 58,559
2024-06-17 2024-06-14
B Purchase
1,250 +2.4%
20.03
USD 25,037 		1,250 +2.4% 20.03 USD 25,037
2023-06-14 2023-06-13
S Sale
577 -18.0%
22.31
USD 12,873 		577 -18.0% 22.31 USD 12,873
2022-03-17 2022-03-16
US OptiNose Inc (OPTN)
S Sale
4,617 -3.2%
2.11
USD 9,742 		4,617 -3.2% 2.11 USD 9,742
2021-12-17 2021-12-16
US OptiNose Inc (OPTN)
S Sale
580 -0.6%
1.64
USD 951 		580 -0.6% 1.64 USD 951
2021-09-17 2021-09-16
US OptiNose Inc (OPTN)
S Sale
578 -0.6%
2.79
USD 1,612 		578 -0.6% 2.79 USD 1,612
2021-06-17 2021-06-17
US OptiNose Inc (OPTN)
S Sale
576 -0.6%
3.73
USD 2,148 		576 -0.6% 3.73 USD 2,148
2021-03-17 2021-03-15
US OptiNose Inc (OPTN)
S Sale
2,304 -2.5%
3.92
USD 9,032 		2,304 -2.5% 3.92 USD 9,032
2020-09-23 2020-09-23
US OptiNose Inc (OPTN)
PP Planned purchase
2,500 +34.5%
3.90
USD 9,743 		2,500 +34.5% 3.90 USD 9,743
// ... existing code ... // ... rest of the file ...